Global Healthcare Investing Conference


Healthcare Executive Workshops

Tuesday – April 29, 2008
The Cleveland Clinic’s INTER-CONTINENTAL HOTEL
Cleveland, OH  44106
Six Continents Room
1:00 p.m

BioEnterprise is hosting a Healthcare Executive Workshop on April 29, 2008 focused on topics of significant value to senior management of early stage bioscience companies.  The Workshop, which brings together an exceptional panel of speakers, is scheduled from 1:00 PM to 5:45 PM at the Intercontinental Hotel with a reception to follow.  The charge for the workshop is $150 with online registration available at the BioEnterprise events page: http://www.bioenterprise.com/events/index.asp.

Following the workshop, BioEnterprise is again co-hosting with IBF Conferences the 2nd Annual GLOBAL HEALTHCARE INVESTING CONFERENCE at the InterContinental Hotel in Cleveland, OH from April 29-May 1, 2008 (http://www.globalhealthcareinvesting.com).  Last year’s inaugural event had over 250 attendees with almost 40% of the attendees representing venture capital and private equity firms and investment bankers.  In addition to the discussion topics that will focus on cross global investment and growth strategies, there will be a series of company presentations featuring non-US based companies that have raised at least one round of professional funding.  These companies will span bioscience interest areas including medical devices, diagnostics, delivery systems, biotechnology and healthcare information technology and services.  Anyone who registers for the IBF Conference will be able to participate in the workshop at no additional charge.

 
Tuesday April 29, 2008
1:00 - 1:45 p.m. How to Raise Capital from Angel Investors David Biondo
Sr. Vice President, Investment Banking
Viscogliosi & Company, Inc.
New York
1:45 - 2:30 p.m. Due Diligence War Room from Day 1 Augustus Denis
Director, Business Development & Corporate Finance
Small Bone Innovations, LLC
New York
2:30 - 3:15 p.m. Developing your IP Strategies:
Tips & Tricks 		Tram Nguyen
Vice President, Intellectual Property
Musculoskeletal Clinical Regulatory Advisers, LLC
New York
3:15 - 3:30 p.m. Break
3:30 - 4:15 p.m. Protecting the Investment:
Operational considerations to ensure ROI 		Kim Gasparelli
President & Chief Technology Officer
Surgisoft
Texas
4:15 - 5:00 p.m. Creating Clinical Studies that Lead to PMA Approval Hollace Rhodes
Director
Orthopedic Regulatory Affairs
Musculoskeletal Clinical Regulatory Advisers, LLC
New York
5:00 - 5:45 p.m. Reimbursement during your Clinical Study Charles Schneider
Vice President, Reimbursement
Musculoskeletal Clinical Regulatory Advisers, LLC
New York
6:00 p.m. Reception